-
-
-
-
-
-
-
10x Genomics (TXG) Misses Q1 EPS by 4c
-
-
-
-
-
-
-
10x Genomics (TXG) Tops Q3 EPS by 7c, Beats on Revenue; Offers Q4 Revenue Guidance
-
-
-
-
-
-
-
10x Genomics (TXG) Tops Q1 EPS by 19c, provides guidance
-
-
-
-
-
-
-
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
-
-
-
-
-
-
-
JPMorgan Downgrades 10X Genomics (TXG) to Neutral
-
-
-
-
-
-
-
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
-
-
-
-
-
-
-
10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023
-
1,231,059 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


